Home › Funds › ARMISTICE CAPITAL, LLC › TMCI
ARMISTICE CAPITAL, LLC position in TMCI
TREACE MED CONCEPTS INC · Health Care
ARMISTICE CAPITAL, LLC reported holding 6,364,000 shares of TMCI (TREACE MED CONCEPTS INC) in its Q2 2026 13F filing — a position valued at US$25.3M, representing 0.33% of its reported portfolio and ranking #45 among its reported holdings. ARMISTICE CAPITAL, LLC has disclosed TMCI holdings in 11 of the last 11 reported quarters, going back to Q4 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How ARMISTICE CAPITAL, LLC's TMCI position evolved
ARMISTICE CAPITAL, LLC first disclosed a stake in TMCI in Q4 2023 at 2,856,000 shares (US$36.4M). The position peaked in Q1 2025 at 6,211,000 shares, worth US$52.1M. Across 11 filings, ARMISTICE CAPITAL, LLC increased the stake 5 time(s), trimmed it 1 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 6,364,000 shares valued at US$25.3M. Notable position changes include a 123% increase in Q2 2024 (shares fell 13% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 2.86M | $36.41M | New |
| Q1 2024 | 2.40M | $31.32M | Reduce |
| Q2 2024 | 5.36M | $35.64M | Add |
| Q3 2024 | 6.20M | $35.94M | Add |
| Q4 2024 | 6.21M | $46.19M | Hold |
| Q1 2025 | 6.21M | $52.11M | Hold |
| Q2 2025 | 6.26M | $36.81M | Add |
| Q3 2025 | 6.32M | $42.38M | Add |
| Q4 2025 | 6.36M | $15.59M | Add |
| Q1 2026 | 6.36M | $8.53M | Hold |
| Q2 2026 | 6.36M | $25.33M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TMCI and 13F data
TMCI (TREACE MED CONCEPTS INC) is a Health Care company. 20 other funds we track also report a position in TMCI — the largest reported positions include GAGNON SECURITIES LLC (US$12.1M), Gagnon Advisors, LLC (US$6.1M), WEBER CAPITAL MANAGEMENT LLC /ADV (US$2.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TMCI
- GAGNON SECURITIES LLC 3.03M sh · $12.06M · Q2 2026
- Gagnon Advisors, LLC 1.53M sh · $6.11M · Q2 2026
- WEBER CAPITAL MANAGEMENT LLC /ADV 589.62K sh · $2.62M · Q3 2026
More on ARMISTICE CAPITAL, LLC
FAQ
How long has ARMISTICE CAPITAL, LLC held TMCI?
ARMISTICE CAPITAL, LLC has disclosed TMCI holdings in 11 of the last 11 reported quarters, going back to Q4 2023.
What is ARMISTICE CAPITAL, LLC's current position in TMCI?
As of Q2 2026, ARMISTICE CAPITAL, LLC holds 6.36M shares of TMCI (TREACE MED CONCEPTS INC), valued at $25.33M, representing 0.33% of its reported portfolio and ranking #45.
Has ARMISTICE CAPITAL, LLC been buying or selling TMCI?
In the latest 13F filing (Q2 2026), ARMISTICE CAPITAL, LLC held unchanged its position in TMCI. The position peaked in Q1 2025 at 6.21M shares.
Which other funds hold TMCI?
Other major institutional holders of TMCI include GAGNON SECURITIES LLC, Gagnon Advisors, LLC, WEBER CAPITAL MANAGEMENT LLC /ADV, among 20 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.